Stocks · Health care · Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Clue Score32
United States Fiscal year ends December CIK 0001061983 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Fady Ibraham Malik
3 Nov 2026
EVP Research & Development
Sold after exercise
3,500
$62.93
$220.26K
Robert I Blum
2 Nov 2026
President & CEO
Sold after exercise
7,500
$62.81
$471.08K
Fady Ibraham Malik
20 Oct 2026
EVP Research & Development
Sold after exercise
3,500
$64.01
$224.04K
Robert I Blum
12 Oct 2026
President & CEO
Sold after exercise
7,500
$62.88
$471.60K
Fady Ibraham Malik
6 Oct 2026
EVP Research & Development
Sold after exercise
3,500
$61.38
$214.83K
Robert I Blum
28 Sep 2026
President & CEO
Sold after exercise
7,500
$65.46
$490.95K
Fady Ibraham Malik
22 Sep 2026
EVP Research & Development
Sold after exercise
3,500
$68.29
$239.02K
Robert I Blum
15 Sep 2026
President & CEO
Sold on a plan indirect
97,926
$69.33
$6.79M
Robert E Landry
15 Sep 2026
Director
Sold on a plan
1,000
$72.13
$72.13K
Robert I Blum
14 Sep 2026
President & CEO
Sold after exercise
7,500
$73.44
$550.80K
Robert E Landry
11 Sep 2026
Director
Sold on a plan
1,000
$74.66
$74.66K
Fady Ibraham Malik
8 Sep 2026
EVP Research & Development
Sold after exercise
3,500
$75.46
$264.11K
B Lynne Parshall
1 Sep 2026
Director
Sold on a plan
5,000
$71.48
$357.40K
Robert I Blum
31 Aug 2026
President & CEO
Sold after exercise
7,500
$70.24
$526.80K
Andrew Callos
31 Aug 2026
EVP, Chief Commercial Officer
Sold after exercise
10,000
$70.24
$702.40K
Fady Ibraham Malik
18 Aug 2026
EVP Research & Development
Sold after exercise
3,500
$75.82
$265.37K
Robert I Blum
10 Aug 2026
President & CEO
Sold after exercise
7,500
$76.76
$575.70K
Andrew Callos
30 Jul 2026
EVP, Chief Commercial Officer
Sold after exercise
14,000
$79.88
$1.12M
Robert I Blum
27 Jul 2026
President & CEO
Sold after exercise
7,500
$80.87
$606.53K
Fady Ibraham Malik
21 Jul 2026
EVP Research & Development
Sold after exercise
3,500
$80.59
$282.07K
Robert I Blum
13 Jul 2026
President & CEO
Sold after exercise
7,490
$82.02
$614.33K
Robert I Blum
13 Jul 2026
President & CEO
Sold after exercise
10
$82.02
$820.20
Fady Ibraham Malik
7 Jul 2026
EVP Research & Development
Sold after exercise
3,500
$86.62
$303.17K
Sung Lee
1 Jul 2026
EVP, Chief Financial Officer
Sold after exercise
1,112
$87.79
$97.62K
Andrew Callos
1 Jul 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$85.80
$1.29M
Robert I Blum
1 Jul 2026
President & CEO
Sold on a plan
7,500
$84.92
$636.90K
Sung Lee
29 Jun 2026
EVP, Chief Financial Officer
Sold after exercise
3,134
$85.00
$266.39K
Sung Lee
24 Jun 2026
EVP, Chief Financial Officer
Sold after exercise
38,730
$82.30
$3.19M
Fady Ibraham Malik
23 Jun 2026
EVP Research & Development
Sold after exercise
3,500
$79.51
$278.29K
Robert I Blum
15 Jun 2026
President & CEO
Sold on a plan
7,500
$70.46
$528.45K
Fady Ibraham Malik
9 Jun 2026
EVP Research & Development
Sold after exercise
3,500
$67.98
$237.93K
B Lynne Parshall
1 Jun 2026
Director
Sold on a plan
5,000
$74.08
$370.40K
Andrew Callos
1 Jun 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$74.08
$1.11M
Edward M. MD Kaye
1 Jun 2026
Director
Sold on a plan
2,933
$76.09
$223.17K
Robert I Blum
27 May 2026
President & CEO
Sold on a plan
7,500
$77.21
$579.08K
Fady Ibraham Malik
19 May 2026
EVP Research & Development
Sold after exercise
3,500
$75.69
$264.92K
Robert I Blum
14 May 2026
President & CEO
Sold on a plan
7,500
$77.92
$584.40K
Andrew Callos
5 May 2026
EVP, Chief Commercial Officer
Sold after exercise
11,333
$77.25
$875.47K
John T Henderson
5 May 2026
Director
Sold after exercise
20,000
$75.97
$1.52M
Sung Lee
5 May 2026
EVP, Chief Financial Officer
Sold on a plan
23,906
$76.87
$1.84M
Wendell Wierenga
5 May 2026
Director
Sold after exercise
4,032
$75.00
$302.40K
Fady Ibraham Malik
5 May 2026
EVP Research & Development
Sold after exercise
3,500
$77.37
$270.80K
Andrew Callos
1 May 2026
EVP, Chief Commercial Officer
Sold after exercise
15,857
$65.00
$1.03M
Andrew Callos
30 Apr 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$63.26
$948.90K
Robert I Blum
29 Apr 2026
President & CEO
Sold on a plan
7,500
$59.62
$447.15K
Fady Ibraham Malik
21 Apr 2026
EVP Research & Development
Sold after exercise
3,500
$65.69
$229.92K
Robert I Blum
15 Apr 2026
President & CEO
Sold on a plan
7,500
$65.38
$490.35K
Andrew Callos
15 Apr 2026
EVP, Chief Commercial Officer
Sold on a plan
7,449
$66.02
$491.78K
Fady Ibraham Malik
7 Apr 2026
EVP Research & Development
Sold after exercise
1,000
$64.75
$64.75K
Fady Ibraham Malik
7 Apr 2026
EVP Research & Development
Sold after exercise
3,500
$65.21
$228.24K
Robert I Blum
1 Apr 2026
President & CEO
Sold on a plan
7,500
$66.63
$499.73K
Andrew Callos
31 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
3,639
$65.00
$236.54K
Andrew Callos
18 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
1,930
$62.07
$119.80K
Robert I Blum
17 Mar 2026
President & CEO
Sell
23,928
$62.15
$1.49M
Robert I Blum
17 Mar 2026
President & CEO
Sell
12,673
$62.15
$787.63K
Fady Ibraham Malik
17 Mar 2026
EVP Research & Development
Sell
4,397
$62.15
$273.27K
Fady Ibraham Malik
17 Mar 2026
EVP Research & Development
Sell
7,636
$62.15
$474.58K
Andrew Callos
17 Mar 2026
EVP, Chief Commercial Officer
Sell
2,916
$62.15
$181.23K
Andrew Callos
17 Mar 2026
EVP, Chief Commercial Officer
Sell
5,626
$62.15
$349.66K
Sung Lee
17 Mar 2026
EVP, Chief Financial Officer
Sell
4,935
$62.15
$306.71K
Andrew Callos
16 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
1,709
$61.03
$104.30K
Robert I Blum
9 Mar 2026
President & CEO
Sell
7,931
$60.72
$481.57K
Fady Ibraham Malik
9 Mar 2026
EVP Research & Development
Sell
2,907
$60.72
$176.51K
Andrew Callos
9 Mar 2026
EVP, Chief Commercial Officer
Sell
2,582
$60.72
$156.78K
Andrew Callos
5 Mar 2026
EVP, Chief Commercial Officer
Sold after exercise
11,000
$61.88
$680.68K
Andrew Callos
5 Mar 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$61.87
$928.05K
Andrew Callos
2 Mar 2026
EVP, Chief Commercial Officer
Sold after exercise
886
$61.62
$54.60K
B Lynne Parshall
2 Mar 2026
Director
Sold on a plan
5,000
$61.21
$306.05K
Andrew Callos
5 Feb 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$61.93
$928.95K
Andrew Callos
2 Feb 2026
EVP, Chief Commercial Officer
Sold after exercise
886
$62.10
$55.02K
Andrew Callos
5 Jan 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$60.28
$904.20K
Andrew Callos
2 Jan 2026
EVP, Chief Commercial Officer
Sold after exercise
885
$63.16
$55.90K
Andrew Callos
2 Jan 2026
EVP, Chief Commercial Officer
Sold after exercise
913
$62.09
$56.69K
Andrew Callos
29 Dec 2025
EVP, Chief Commercial Officer
Sold on a plan
1,809
$62.44
$112.95K
Wendell Wierenga
22 Dec 2025
Director
Sold after exercise
20,000
$66.14
$1.32M
Robert I Blum
22 Dec 2025
President & CEO
Exercised, kept
16,506
$6.67
$110.10K
Robert I Blum
22 Dec 2025
President & CEO
Exercised, kept
54,727
$6.67
$365.03K
Fady Ibraham Malik
16 Dec 2025
EVP Research & Development
Sold after exercise
2,200
$61.24
$134.73K
Andrew Callos
8 Dec 2025
EVP, Chief Commercial Officer
Sold after exercise
1,042
$65.96
$68.73K
Andrew Callos
5 Dec 2025
EVP, Chief Commercial Officer
Sold after exercise
52,486
$65.95
$3.46M
Fady Ibraham Malik
2 Dec 2025
EVP Research & Development
Sold after exercise
2,200
$63.89
$140.56K
John T Henderson
2 Dec 2025
Director
Sold after exercise
8,750
$63.90
$559.13K
Robert Arthur Harrington
1 Dec 2025
Director
Sold on a plan
2,150
$66.80
$143.62K
Edward M. MD Kaye
1 Dec 2025
Director
Sold after exercise
28,064
$66.72
$1.87M
B Lynne Parshall
19 Nov 2025
Director
Sold on a plan
5,000
$64.73
$323.65K
Fady Ibraham Malik
18 Nov 2025
EVP Research & Development
Sold after exercise
2,200
$66.45
$146.19K
Edward M. MD Kaye
11 Nov 2025
Director
Sold after exercise
5,175
$65.08
$336.79K

What was left out

Form 4 filings counted 125
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 53
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 1,087,174
History held since 3 Oct 2006